Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106009554 | 10600955 | 4 | F | 20141001 | 20160629 | 20141124 | 20160707 | EXP | FR-ASTELLAS-2014US014594 | ASTELLAS | 57.48 | YR | F | Y | 0.00000 | 20160707 | CN | GB | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106009554 | 10600955 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | Y | 21743 | 150 | MG | TABLET | QD | ||||||
| 106009554 | 10600955 | 2 | SS | PEMETREXED | PEMETREXED | 1 | Intravenous (not otherwise specified) | Y | 0 | 600 | MG | FORMULATION UNKNOWN | |||||||
| 106009554 | 10600955 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | Y | 0 | 90 | MG | FORMULATION UNKNOWN | QD | ||||||
| 106009554 | 10600955 | 4 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 106009554 | 10600955 | 5 | SS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 106009554 | 10600955 | 6 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 106009554 | 10600955 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106009554 | 10600955 | 1 | Lung neoplasm malignant |
| 106009554 | 10600955 | 2 | Lung neoplasm malignant |
| 106009554 | 10600955 | 3 | Lung neoplasm malignant |
| 106009554 | 10600955 | 4 | Nausea |
| 106009554 | 10600955 | 5 | Hypertension |
| 106009554 | 10600955 | 6 | Product used for unknown indication |
| 106009554 | 10600955 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106009554 | 10600955 | HO |
| 106009554 | 10600955 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106009554 | 10600955 | Acute kidney injury | |
| 106009554 | 10600955 | Diarrhoea | |
| 106009554 | 10600955 | Drug interaction | |
| 106009554 | 10600955 | Hypokalaemia | |
| 106009554 | 10600955 | Hyponatraemia | |
| 106009554 | 10600955 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106009554 | 10600955 | 1 | 20140731 | 20141001 | 0 | |
| 106009554 | 10600955 | 2 | 20140806 | 20140916 | 0 | |
| 106009554 | 10600955 | 3 | 20140806 | 20140916 | 0 |